FDA Inspection
Institute of Regenerative and Cellular MedicineInstitute of Regenerative and Cellular Medicine – FDA Inspection, Oct 19, 2021
Record Details
This FDA Inspection record concerns Institute of Regenerative and Cellular Medicine, with an inspection on October 19, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 19, 2021
- Product Type
- Biologics
View Company Profile
ID · 0c8e5f6e-7c9c-4576-bab0-dd2e6893647c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1155145
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.115(a)(3)Records of continuing review
- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.106(e)Changes re: review new products or discontinue reviewing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Institute of Regenerative and Cellular Medicine
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 12, 2016 | VAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Institute of Regenerative and Cellular Medicine
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.